APA (7th ed.) Citation

R, M., D, D., V, C., G, L., C, S., P, R., . . . R, L. G. (2022). Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates. Nature communications, 13(1), 5108. https://doi.org/10.1038/s41467-022-32565-w

Chicago Style (17th ed.) Citation

R, Marlin, et al. "Antiviral Efficacy of Favipiravir Against Zika and SARS-CoV-2 Viruses in Non-human Primates." Nature Communications 13, no. 1 (2022): 5108. https://doi.org/10.1038/s41467-022-32565-w.

MLA (9th ed.) Citation

R, Marlin, et al. "Antiviral Efficacy of Favipiravir Against Zika and SARS-CoV-2 Viruses in Non-human Primates." Nature Communications, vol. 13, no. 1, 2022, p. 5108, https://doi.org/10.1038/s41467-022-32565-w.